The latest episode of the MLB Trade Rumors Podcast is now live on Spotify, Apple Podcasts, and wherever you get your podcasts! Make sure you subscribe as well! You can also use the player at this link to listen, if you don’t use Spotify or Apple for podcasts.
This week, host Darragh McDonald is joined by Anthony Franco of MLB Trade Rumors to discuss…
Plus, we answer your questions, including…
Matthew Boyd has already surpassed his highest innings total since 2019. How far do the Cubs push him over the remainder of the season? (32:05) The Padres and Royals have pitching they could trade but should they? (38:20) The Reds don’t have long-term answers at first base, third base, left field, right field or designated hitter. Is there a path to bring in players from outside the organization? (45:40)Check out our past episodes!
Reacting To The Devers Trade And Aaron Civale – listen here White Sox Ownership, Roman Anthony, And The Diamondbacks’ Rotation – listen here Jarren Duran Rumors, Caglianone And Young Promoted, And Pitching Injuries – listen hereThe podcast intro and outro song “So Long” is provided courtesy of the band Showoff. Check out their Facebook page here!
Photo courtesy of Robert Edwards, Imagn Images
Hence then, the article about mlbtr podcast the braves say they won t sell jeimer candelario dfa d and injured d backs was published today ( ) and is available on MLBtraderumors ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( MLBTR Podcast: The Braves Say They Won’t Sell, Jeimer Candelario DFA’d, And Injured D-Backs )
Also on site :
- commercetools Kicks Off NRF 2026 - including Updates on Stripe ACS, AI Hub, and Helping Enterprises Stay Discoverable and Shoppable in Agentic Commerce
- inDrive turns to ads and groceries to diversify revenue
- Clover Initiates Phase 2 Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates